CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

被引:177
|
作者
Trzonkowski, P [1 ]
Szmit, E [1 ]
Mysliwska, J [1 ]
Dobyszuk, A [1 ]
Mysliwski, A [1 ]
机构
[1] Med Acad Gdansk, Dept Histol & Immunol, PL-80211 Gdansk, Poland
关键词
CD4(+)CD25(+) cells; T regulatory cells; cytotoxicity; target/effector formation; CD8(+) lymphocytes; NK lymphocytes; interleukin; 10;
D O I
10.1016/j.clim.2004.04.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There are reports suggesting an influence of CD4(+)CD25(+) T regulatory cells (Treg) on cytotoxic lymphocytes. The aim of the study was to evaluate such an influence. Cytotoxic activity was examined in the cultures of peripheral blood mononuclear cells (PBMC) as well as in the cultures of separate T CD8(+) or NK cells mixed with Treg and other subpopulations of PBMC. We found that the production of IFNgamma, perforin and cytotoxic activity of T CD8(+) or NK cells were decreased in the presence of Treg, however, the percentage of conjugates formed by cytotoxic cells with target cells during cytotoxic reaction was decreased only in the cultures of T CD8(+) cells. Inhibition of the cytotoxic reactions in the presence of Treg cells was found to be associated with the generation of conglomerates formed by CD4(+)CD25(+) and the cytotoxic cells, as observed under the fluorescence microscope. Treg produced IL10 when mixed with the cytotoxic lymphocytes, however, an addition of anti-IL10 mAb into the cultures did not affect the results. It is concluded that Treg were able to inhibit both T CD8(+) and NK lymphocyte cytotoxic activities in a direct cell-to-cell interaction. Treg decreased the number of T CD8(+) cells attached to the target cells, while the mechanism underlying a decrease in NK cytotoxicity remained unclear. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:258 / 267
页数:10
相关论文
共 50 条
  • [41] Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation
    Dubois, B
    Chapat, L
    Goubier, A
    Papiernik, M
    Nicolas, JF
    Kaiserlian, D
    BLOOD, 2003, 102 (09) : 3295 - 3301
  • [42] Cure of colitis by CD4+CD25+ regulatory T cells
    Mottet, C
    Uhlig, HH
    Powrie, F
    GASTROENTEROLOGY, 2004, 126 (04) : A283 - A283
  • [43] CD4+CD25+ regulatory T cells in HIV infection
    Nixon, DF
    Aandahl, EM
    Michaëlsson, J
    MICROBES AND INFECTION, 2005, 7 (7-8) : 1063 - 1065
  • [44] CD4+CD25+ T regulatory cells in renal transplantation
    Cheung, Jason
    Zahorowska, Beata
    Suranyi, Michael
    Wong, Jeffrey K. W.
    Diep, Jason
    Spicer, Stephen T. T.
    Verma, Nirupama D. D.
    Hodgkinson, Suzanne J.
    Hall, Bruce M. M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] CD4+CD25+ regulatory T cells and their therapeutic potential
    Randolph, DA
    Fathman, CG
    ANNUAL REVIEW OF MEDICINE, 2006, 57 : 381 - 402
  • [46] CD4+CD25+ regulatory T cells in health and disease
    Liu, HY
    Leung, BP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (5-6): : 519 - 524
  • [47] CD4+CD25+ T regulatory cells in murine pregnancy
    Zenclussen, AC
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 65 (02) : 101 - 110
  • [49] Hematopoietic progenitor cell regulation by CD4+CD25+ T cells
    Urbieta, Maite
    Barao, Isabel
    Jones, Monica
    Jurecic, Roland
    Panoskaltsis-Mortari, Angela
    Blazar, Bruce R.
    Murphy, William J.
    Levy, Robert B.
    BLOOD, 2010, 115 (23) : 4934 - 4943
  • [50] Role of CD4+CD25+ regulatory T cells in allospecific tumor cell killing in vitro
    Drago, KF
    Hoffman, P
    Negrin, JER
    Edinger, M
    FASEB JOURNAL, 2003, 17 (07): : C78 - C78